AbbVie Inc. (ABBV) vs NVIDIA Corporation (NVDA)
A side-by-side comparison of AbbVie Inc. and NVIDIA Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; NVDA is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
NVDA
NVIDIA Corporation
$218.29TechnologyDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — ABBV vs NVDA
growth of $100 · dividends reinvested · last 10yABBV +506.9% (+19.8%/yr)NVDA +14538.6% (+64.6%/yr)NVDA compounded faster over this window
Log scale — wide-divergence pair
ABBV NVDA
ABBV vs NVDA: by the numbers
- •NVDA is the larger company ($5.29T vs $454.17B market cap).
- •NVDA trades at the lower trailing earnings multiple (27.60 vs 72.43 P/E), one valuation lens rather than an overall verdict.
- •NVDA converts more revenue to profit (63.66% vs 9.81% net margin).
- •NVDA grew revenue faster over the past five years (69.34% vs 3.69% CAGR).
- •ABBV pays the higher dividend yield (2.68% vs 0.13%).
Metrics side by side
Valuation
| Metric | ABBV | NVDA |
|---|---|---|
| P/E ratio | 72.43 | 27.60 |
| Forward P/E | 18.32 | 23.59 |
| P/S ratio | 7.05 | 17.45 |
| P/B ratio | N/A | 23.09 |
| EV / EBITDA | 19.34 | 26.35 |
| FCF yield | 3.99% | 2.40% |
Profitability
| Metric | ABBV | NVDA |
|---|---|---|
| Gross margin | 71.48% | 74.67% |
| Operating margin | 29.32% | 65.21% |
| Net margin | 9.81% | 63.66% |
| ROE | N/A | 84.23% |
| ROIC | 13.46% | 59.61% |
Dividends
| Metric | ABBV | NVDA |
|---|---|---|
| Dividend yield | 2.68% | 0.13% |
| Payout ratio | 192.43% | 3.54% |
Growth (annualized)
| Metric | ABBV | NVDA |
|---|---|---|
| Revenue CAGR (5Y) | 3.69% | 69.34% |
| EPS CAGR (5Y) | -2.79% | 94.31% |
| FCF CAGR (5Y) | 0.11% | 82.12% |
| Total return CAGR (5Y) | 23.51% | 57.72% |
Frequently asked
- Which has the lower trailing P/E, ABBV or NVDA?
- NVDA has the lower trailing P/E: ABBV trades at 72.43 and NVDA at 27.60. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or NVDA?
- Over the past five years, NVDA grew revenue faster — ABBV at a 3.69% CAGR versus NVDA at 69.34%.
- Does ABBV or NVDA pay a bigger dividend?
- ABBV yields 2.68% and NVDA yields 0.13% based on trailing dividends and the latest price.
- Is ABBV or NVDA more profitable?
- NVDA runs the higher net margin — ABBV at 9.81% versus NVDA at 63.66%.
- How have ABBV and NVDA total returns compared?
- Over the past 10 years, ABBV delivered 19.76% and NVDA delivered 64.96% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioNVIDIA P/E ratioAbbVie dividend yieldNVIDIA dividend yieldAbbVie ROENVIDIA ROEAbbVie operating marginNVIDIA operating marginAbbVie revenue growthNVIDIA revenue growthAbbVie free cash flowNVIDIA free cash flow
AbbVie & NVIDIA appear in these rankings
Highest Dividend Yield Stocks25+ Year Dividend GrowersFastest Revenue Growth StocksHighest ROE Stocks
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.